Skip to main content
. 2021 Jul 26;15(6):773–788. doi: 10.4162/nrp.2021.15.6.773

Table 6. Other types of cancer risk stratified by garlic intake.

Author, Year [Reference] Cancer outcome Follow-up Garlic intake No. Adjusted RR 95% CI
Dorant, 1994 [32] Lung cancer 3.3 yrs Garlic suppl vs. no suppl 48 vs. 419 1.22 (0.81, 1.86)
Lung cancer Exclusively garlic suppl vs. no suppl 29 vs. 419 1.78 (1.08, 2.92)
Dorant, 1995 [33] Breast cancer 3.3 yrs Garlic suppl vs. no suppl 24 vs. 305 0.75 (0.41, 1.38)
Dorant, 1996 [34] Stomach cancer 3.3 yrs Exclusively garlic suppl vs. no suppl 9 vs. 118 1.27 (0.61, 2.64)
Stomach cancer Garlic + any other suppl vs. any other suppl 5 vs. 20 1.28 (0.45, 3.66)
Satia, 2009 [29] Lung cancer 5 yrs Any garlic suppl use in the past 10 year vs. no use 80 vs. 582 1.05 (0.83, 1.34)
Brasky, 2011 [35] Prostate cancer 6.1 yrs Any garlic suppl use in the past 10 year vs. non-user 190 vs. 1,411 1.00 (0.85, 1.17)
Walter, 2011 [36] Hematologic malignancy 6.5 yrs Low use garlic suppl vs. none 38 vs. 523 1.07 (0.76, 1.51)
Hematologic malignancy High use garlic suppl vs. none 24 vs. 523 0.55 (0.34, 0.87)
Kim, 2018 [37] Gastric cancer 30 yrs Garlic intake 1–4 gloves per week vs. never 45 vs. 31 0.81 (0.50, 1.31)
Gastric cancer Garlic intake ≥ 5 gloves per week vs. never 18 vs. 31 1.34 (0.72, 2.47)
Gastric cancer 30 yrs Garlic intake 1–4 gloves per week vs. never 46 vs. 48 0.98 (0.71, 1.36)
Gastric cancer Garlic intake ≥ 5 gloves per week vs. never 13 vs. 48 1.39 (0.89, 2.17)

RR, relative risk; CI. confidence interval.